Aptargroup (ATR) Income from Non-Controlling Interests (2009 - 2026)
Aptargroup (ATR) posted quarterly Income from Non-Controlling Interests of $285000.0 for Q2 2026, up 2275.0% year-over-year from $12000.0 in Q2 2025, and up 220.22% on a QoQ basis from $89000.0 in Q1 2026.
Aptargroup (ATR) Income from Non-Controlling Interests (2009 - 2026) Analysis & Trends
Aptargroup has reported Income from Non-Controlling Interests for 18 years, with the latest figure at $285000.0 in Q2 2026.
- Income from Non-Controlling Interests for Q2 2026 came in at $285000.0, up 2275.0% year-over-year; the trailing twelve-month figure through Jun 2026 was $168000.0 (up 152.66% YoY), and the FY2025 annual result was -$206000.0, up 43.25% from the prior year.
- Income from Non-Controlling Interests rose to $285000.0 in Q2 2026, from $89000.0 in the prior quarter.
- Over five years, Income from Non-Controlling Interests peaked at $398000.0 in Q4 2022 and troughed at -$178000.0 in Q1 2023.
- A 5-year average of -$20111.1 and a median of -$58000.0 in 2022 frame the typical range for Income from Non-Controlling Interests.
- The widest annual swing landed in 2024, when Income from Non-Controlling Interests plunged 5950.0%; it then surged 2275.0% in 2026.
- A 5-year view of Income from Non-Controlling Interests shows it stood at $398000.0 in 2022, then sank by 127.64% to -$110000.0 in 2023, then rose by 28.18% to -$79000.0 in 2024, then increased by 18.99% to -$64000.0 in 2025, then jumped by 545.31% to $285000.0 in 2026.
- Per Business Quant data, the three most recent Income from Non-Controlling Interests figures were $285000.0 in Q2 2026, $89000.0 in Q1 2026, and -$64000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 6.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 79.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Aptargroup | 8.58 Bn | 8.38 Bn | 365.52 Mn | 285,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 285,000.00 |
| Mar 31, 2026 | 89,000.00 |
| Dec 31, 2025 | -130,000.00 |
| Sep 30, 2025 | 47,000.00 |
| Jun 30, 2025 | 12,000.00 |
| Sep 30, 2024 | -117,000.00 |
| Jun 30, 2024 | 4,000.00 |
| Mar 31, 2024 | -171,000.00 |
| Dec 31, 2023 | 201,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Jun 30, 2023 | -25,000.00 |
| Mar 31, 2023 | -178,000.00 |
| Dec 31, 2022 | 398,000.00 |
| Sep 30, 2022 | -67,000.00 |
| Jun 30, 2022 | -12,000.00 |
| Mar 31, 2022 | -52,000.00 |
| Dec 31, 2021 | -78,000.00 |
| Sep 30, 2021 | -366,000.00 |
| Jun 30, 2021 | -2,000.00 |
| Mar 31, 2021 | -13,000.00 |